TY - JOUR
T1 - The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients
AU - Ikeda, Masaki
AU - Sharma, Vikram
AU - Sumi, S. Mark
AU - Rogaeva, Ekaterina A.
AU - Poorkaj, Parvoneh
AU - Sherrington, Robin
AU - Nee, Linda
AU - Tsuda, Takehide
AU - Oda, Nobuhito
AU - Watanabe, Mitsunori
AU - Aoki, Masashi
AU - Shoji, Mikio
AU - Abe, Koji
AU - Itoyama, Yasuto
AU - Hirai, Shunsaku
AU - Schellenberg, Gerard D.
AU - Bird, Thomas D.
AU - St George-Hyslop, P. H.
PY - 1996/12
Y1 - 1996/12
N2 - We report the clinical and neuropathologic phenotypes associated with two different missense mutations in the presenilin 1 (PS-1) gene in Japanese patients with early-onset familial Alzheimer's disease (FAD). In the AM/JPN1 pedigree a missense mutation (C→T) was found at nucleotide 1102, which is predicted to cause an alanine-to-valine missense substitution at codon 260. In this family, the disease had a mean age of onset of 40.3 years and an indolent course (range, 8-19 years). Neuropathologic studies in 3 members of this pedigree showed widespread senile plaques, neurofibrillary tangles, and neuronal loss, as well as abundant perivascular subpial amyloid deposits in the Virchow-Robin spaces and the presence of Pick-like intraneuronal inclusions in the dentate gyrus. In the second pedigree, transmitting a C→T nucleotide substitution at position 1027, leading to the missense mutation of alanine to valine at codon 285, the disease had a later onset (mean, 51 years) but a more rapid course. Comparison of the disease phenotypes associated with other missense mutations in exon 9 of PS-1 reveals no clinical or pathological phenotype, which uniquely distinguishes Alzheimer's disease associated with PS-1 mutations from other forms of early-onset FAD, implying that direct mutation screening is required to identify these cases.
AB - We report the clinical and neuropathologic phenotypes associated with two different missense mutations in the presenilin 1 (PS-1) gene in Japanese patients with early-onset familial Alzheimer's disease (FAD). In the AM/JPN1 pedigree a missense mutation (C→T) was found at nucleotide 1102, which is predicted to cause an alanine-to-valine missense substitution at codon 260. In this family, the disease had a mean age of onset of 40.3 years and an indolent course (range, 8-19 years). Neuropathologic studies in 3 members of this pedigree showed widespread senile plaques, neurofibrillary tangles, and neuronal loss, as well as abundant perivascular subpial amyloid deposits in the Virchow-Robin spaces and the presence of Pick-like intraneuronal inclusions in the dentate gyrus. In the second pedigree, transmitting a C→T nucleotide substitution at position 1027, leading to the missense mutation of alanine to valine at codon 285, the disease had a later onset (mean, 51 years) but a more rapid course. Comparison of the disease phenotypes associated with other missense mutations in exon 9 of PS-1 reveals no clinical or pathological phenotype, which uniquely distinguishes Alzheimer's disease associated with PS-1 mutations from other forms of early-onset FAD, implying that direct mutation screening is required to identify these cases.
UR - http://www.scopus.com/inward/record.url?scp=8044251536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8044251536&partnerID=8YFLogxK
U2 - 10.1002/ana.410400614
DO - 10.1002/ana.410400614
M3 - Article
C2 - 9007097
AN - SCOPUS:8044251536
SN - 0364-5134
VL - 40
SP - 912
EP - 917
JO - Annals of Neurology
JF - Annals of Neurology
IS - 6
ER -